TrialCancer science2022

Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010).

Hirotsugu Kenmotsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.